February 2 2023
BioCentury’s 2022 class of emerging companies
BioCenturySee all News
kelonia’s lentiviral vector gene delivery platform uses a simple and elegant solution that builds on decades of research, development, and technical experience to and efficiently deliver genetic cargo only to the desired tissue.
kelonia is building a human-first company with the capabilities, experience, care, and commitment to bring genetic medicine to every patient in need.